Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00002902 · COMPLETED

Trial details

NCT number: NCT00002902
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.